U.S. Varicose Vein Treatment Devices Market Size to Hit Around USD 956.83 Mn by 2033

The U.S. varicose vein treatment device market size was exhibited at USD 549.65 million in 2023 and is projected to hit around USD 956.83 million by 2033, growing at a CAGR of 5.7% during the forecast period 2024 to 2033.

Download Free Sample Copy for Better Understanding@ https://www.novaoneadvisor.com/report/sample/8761

U.S. Varicose Vein Treatment Devices Market Key Takeaways:

• The injection sclerotherapy segment accounted for the largest revenue share of 69.0% in 2023.
• The endovenous ablation emerged as the fastest-growing segment.

The market is driven by several critical factors, including the increasing prevalence of varicose veins among the aging population, advancements in minimally invasive treatment technologies, rising awareness and acceptance of cosmetic procedures, and favorable reimbursement policies for vein treatments. According to Beth Israel Deaconess Medical Center, approximately 40 million Americans are affected by varicose veins, which appear swollen, twisted, and bluish veins visible under the skin, typically in the legs or pelvic region. These abnormal dilated blood vessels are common among the U.S. population.

The elderly population is particularly susceptible to developing varicose veins due to significant changes in the structure and function of veins as they age. Individuals over the age of 50 have a 50% chance of being affected by this condition. In addition, overweight persons and pregnant women are at a higher risk. Available treatment options include sclerotherapy, laser therapy, and radiofrequency ablation, with sclerotherapy commonly recommended as the first-line treatment for varicose, spider, and reticular veins.

Advancements in treatment technologies, such as endovenous laser ablation (EVLA) and radiofrequency ablation (RFA), made varicose vein treatments more effective and less invasive. These techniques use heat energy to collapse and seal damaged veins, reducing recovery times and minimizing the risk of complications. For instance, AngioDynamics' VenaCure EVLT is a minimally invasive endovenous laser treatment that provides a proven solution for addressing the root cause of varicose veins. It offers patients a rapid recovery and the ability to resume their normal daily activities quickly.

The increasing emphasis on patient-centered care in healthcare systems contributes to the preference for minimally invasive treatments. Patients are more informed and involved in their treatment decisions, seeking options that offer quicker recovery and less disruption to their lives. This trend aligns with the broader movement towards personalized medicine, where treatments are tailored to meet individual patient needs and preferences, further solidifying the role of minimally invasive procedures in the U.S. market.

U.S. Varicose Vein Treatment Devices Market By Type Insights

The injection sclerotherapy segment accounted for the largest revenue share of 69.0% in 2023 due to its widespread adoption and effectiveness in treating varicose veins. Injection sclerotherapy involves injecting a sclerosant (a substance that causes thrombosis and fibrosis of the vein) directly into the affected vein, leading to its reabsorption and resolution. According to an article published in Cureus in January 2024, sclerotherapy, a crucial treatment for varicose veins, is broadly analyzed, encompassing liquid and foam techniques. Foam sclerotherapy stands out for its enhanced efficacy. The study offers an in-depth comparison of these modalities, underscoring variations in technical success, recurrence rates, and cost-effectiveness.

The endovenous ablation emerged as the fastest-growing segment. This growth can be attributed to the increasing prevalence of varicose veins among the aging population, necessitating effective and minimally invasive treatment options. Endovenous ablation techniques, including radiofrequency ablation (RFA) and laser ablation (EVLA), offer significant advantages over traditional surgical methods including vein stripping, reduced recovery times, lower complication rates, and improved patient comfort. According to the National Library of Medicine, radiofrequency ablation is a minimally invasive, image-guided procedure conducted in outpatient settings using local anesthesia. It requires a performing operator, a nursing assistant, and a trained ultrasound technician.

U.S. Varicose Vein Treatment Devices Market Recent Developments

• In June 2023, Theraclion received FDA clearance to initiate a pivotal clinical trial in the U.S. and Europe. The multicenter study, named VEINRESET, will evaluate the Sonovein device for treating primary insufficiency of great saphenous veins at four centers.
• In April 2022, Ra Medical Systems, Inc. announced that the U.S. Patent and Trademark Office granted a patent for liquid-filled laser ablation with expanded distal optical windows.

Some of the prominent players in the U.S. varicose vein treatment device market include:

• Medtronic
• AngioDynamics
• Candela Corporation
• Lumenis Be Ltd.
• biolitec Holding GmbH & Co KG
• Eufoton s.r.l.
• Energist
• Quanta System

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to com

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. varicose vein treatment device market

Type

• Endovenous Ablation

• Endovenous Laser Therapy
• Radiofrequency Ablation

• Sclerotherapy
• Surgical Ligation/Stripping

Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/8761?

Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com

You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333

About US

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Connect with Us

Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

IND Address: 2nd Floor,Shreeleela Plaza, Baner Road, Pune, Maharashtra - 411045

Call: USA - +1 650 460 3308 | IND - +91 87933 22019

[email protected]

Web: https://www.novaoneadvisor.com/

Nova One Advisor Group Offer Other Reports:

Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.

Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.

Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.

Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.

U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.

U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.

T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.

Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market?size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.

Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.

Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.

U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.